AMIT is the Technion hub for biomedical innovation; it supports the development and commercialization of exceptional inventions conceived by Technion researchers with a mission to bring to market promising biomedical technology.
|2017-09-27||Colospan||Series A||$7.7M||Clal Biotechnology Industries, Docor International Management, and TriVentures|
|2017-06-07||Voiceitt||Seed VC||$2M||1000 Angels, Buffalo Angels, Cahn Capital, DreamIt Ventures, and Quake Capital|
|2017-06-07||Talkitt||Series A||$2M||Buffalo Angels, Cahn Capital, DreamIt Ventures, Quake Capital, and Undisclosed Angel Investors|
|2015-07-29||Eximo Medical||Series A||$1.6M||Accelmed, and Technion Research & Development Foundation|